CMS Eyes Proposed Rule With Device Identifiers In Claims Forms

Why It Matters

Embedding UDIs in claims creates a nationwide data set that can quickly identify unsafe devices, reducing adverse events and lowering reimbursement expenses.

Key Takeaways

• CMS to require UDIs on Medicare/Medicaid claims.
• Lawmakers have pushed for device traceability.
• UDI data can flag faulty devices early.
• Potential taxpayer savings from reduced device failures.
• Providers must update billing systems for compliance.

Pulse Analysis

The Centers for Medicare & Medicaid Services (CMS) is poised to issue a proposed rule that mandates the inclusion of Unique Device Identifiers (UDIs) on all Medicare and Medicaid claim submissions. UDIs—standardized alphanumeric codes assigned by manufacturers—have been a cornerstone of the FDA’s post‑market surveillance strategy, yet their integration into claims data has lagged. By aligning billing processes with the UDI framework, CMS seeks to close a critical data gap, enabling regulators and payers to track device performance across the entire health‑care continuum.

For providers and payers, the rule signals a shift toward more granular analytics and tighter compliance requirements. Hospitals will need to upgrade electronic health record (EHR) and practice management systems to capture and transmit UDI information alongside traditional procedure codes. Payers, in turn, can leverage this enriched data set to flag anomalous reimbursement patterns, identify devices linked to adverse events, and negotiate value‑based contracts with manufacturers. The downstream effect is a more proactive safety net that can prevent costly recalls and protect patients from preventable harm.

The policy push reflects sustained pressure from Congress, which has highlighted the fiscal and clinical risks of opaque device tracking. As the rule moves through the notice‑and‑comment period, industry groups are likely to lobby for realistic implementation timelines and technical guidance. Successful adoption could unlock significant taxpayer savings—estimates suggest billions in avoided costs from early detection of defective devices—while setting a new standard for data‑driven health‑care oversight.